Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain-gut axis imaging, motion correction with [ <sup>11</sup> C]-carfentanil total-body PET.

medRxiv : the preprint server for health sciences·2026
Same author

Evaluating the tumour detection efficacy of [<sup>18</sup>F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal model.

Nuclear medicine and biology·2026
Same author

Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein.

Journal of Parkinson's disease·2026
Same author

Machine learning prediction of multiple distinct high-affinity chemotypes for α-synuclein fibrils.

Chemical communications (Cambridge, England)·2026
Same author

In vivo imaging of reactive oxygen species after myocardial ischemia-reperfusion injury: a large animal multimodal imaging and transcriptomic study.

bioRxiv : the preprint server for biology·2025
Same author

Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine.

medRxiv : the preprint server for health sciences·2025
Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.5K

Molecular Imaging: PARP-1 and Beyond.

Laura N Puentes1, Mehran Makvandi2, Robert H Mach3

  • 1Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; and.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|February 13, 2021
PubMed
Summary
This summary is machine-generated.

Molecular imaging advances enable visualization of DNA damage and repair, aiding disease detection and treatment monitoring. Poly[adenosine diphosphate ribose]polymerase-1 shows promise as a biomarker for therapy response.

Keywords:
DNAPARP-1PET/CTimagingmolecular imagingradiopharmaceuticals

More Related Videos

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
10:12

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

3.2K
Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions
12:43

Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions

Published on: November 12, 2017

11.2K

Related Experiment Videos

Last Updated: Nov 17, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.5K
Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
10:12

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

3.2K
Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions
12:43

Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions

Published on: November 12, 2017

11.2K

Area of Science:

  • Biomedical imaging
  • Molecular biology
  • Genetics

Background:

  • DNA damage is implicated in nearly all diseases, driving pathogenesis.
  • DNA repair mechanisms are crucial for maintaining genomic stability.
  • Targeting DNA damage response proteins is a key strategy in cancer therapy.

Purpose of the Study:

  • To review recent advancements in molecular imaging of DNA damage and repair.
  • To highlight the role of imaging in precision medicine for patient stratification and therapy monitoring.
  • To focus on poly[adenosine diphosphate ribose]polymerase-1 (PARP-1) as an imaging target and predictive biomarker.

Main Methods:

  • Review of literature on molecular imaging of DNA damage and repair over the past 5 years.
  • Emphasis on Positron Emission Tomography (PET) applications.
  • Discussion of PARP-1 as a specific imaging target.

Main Results:

  • Molecular imaging tools targeting DNA damage response proteins are emerging.
  • PET imaging facilitates early cancer detection and monitoring of treatment efficacy.
  • PARP-1 imaging can potentially stratify patients and predict response to therapy.

Conclusions:

  • Molecular imaging of DNA damage and repair is a rapidly evolving field.
  • Imaging provides a direct measure of drug target engagement and therapeutic response.
  • PARP-1 represents a significant target for molecular imaging in precision oncology.